Loblaw, parent company settle bread price-fixing lawsuits

Access to abortion services at the local level in Ontario substantially increased within a five-year period after a drug known as mifepristone became available for use in Canada in 2017, according to newly released findings.A study published Monday in the Canadian Medical Association Journal sheds light on how mifepristone dispensed by local pharmacies in the country’s most populous province changed access to services.